The effect of pleural fluid content on the development of pleural thickness. 2002

E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
Department of Respiratory Diseases, GATA Camlica Chest Diseases Hospital, Istanbul, Turkey. erkunter@hotmail.com

METHODS Residual pleural thickness (RPT) is a common complication of tuberculous pleurisy (TP), and the degree of RPT cannot be predicted in advance. OBJECTIVE To determine whether pleural fluid content has an effect on the development of RPT. METHODS Forty-seven patients with TP were enrolled in the study. A set of biochemical tests: lactate dehydrogenase, glucose, total proteins, adenosine deaminase, tumour necrosis factor alpha (TNF-alpha), alpha-1 acid glycoprotein (AAG), alpha-2 macroglobulin, C-reactive protein (CRP), complement 3 and complement 4 were studied in the pleural fluid samples. After 6 months of anti-tuberculosis treatment, patients were re-evaluated for RPT. RPT was defined in a posteroanterior chest radiograph as a pleural space of >2 mm or >10 mm measured in the lower lateral chest at the level of an imaginary horizontal line intersecting the diaphragmatic dome. RESULTS Seventeen patients (36.17%) had an RPT of <2 mm, 18 (38.29%) had an RPT of 2-10 mm, and 12 (25.53%) had an RPT of >10 mm. TNF-alpha levels were lower in patients with an RPT of <2 mm than in patients with an RPT of 2-10 mm or >10 mm (P < 0.05 and P < 0.01, respectively). The level of TNF-alpha was higher in patients with an RPT of >10 mm compared to the 2-10 mm group (P < 0.05). Meanwhile, pleural fluid glucose, AAG and CRP concentrations were significantly higher in patients with an RPT of >10 mm than in patients with <2 mm RPT (P < 0.05, P < 0.01, and P < 0.05, respectively). CONCLUSIONS In TP, the development and degree of RPT are significantly correlated to the glucose, CRP, AAG, and TNF-alpha levels in the pleural fluid.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009961 Orosomucoid Acid Seromucoid,Seromucoid,Serum Sialomucin,alpha 1-Acid Glycoprotein,alpha 1-Acid Seromucoid,A(1)-Acid Seromucoid,Acid alpha 1-Glycoprotein,Alpha(1)-Acid Glycoprotein,alpha 1-Acid Glycoprotein (Acute Phase),alpha 1-Glycoprotein Acid,Acid alpha 1 Glycoprotein,Glycoprotein, alpha 1-Acid,Seromucoid, Acid,Seromucoid, alpha 1-Acid,Sialomucin, Serum,alpha 1 Acid Glycoprotein,alpha 1 Acid Seromucoid,alpha 1 Glycoprotein Acid
D010994 Pleura The thin serous membrane enveloping the lungs (LUNG) and lining the THORACIC CAVITY. Pleura consist of two layers, the inner visceral pleura lying next to the pulmonary parenchyma and the outer parietal pleura. Between the two layers is the PLEURAL CAVITY which contains a thin film of liquid. Parietal Pleura,Visceral Pleura,Pleura, Parietal,Pleura, Visceral
D010996 Pleural Effusion Presence of fluid in the pleural cavity resulting from excessive transudation or exudation from the pleural surfaces. It is a sign of disease and not a diagnosis in itself. Effusion, Pleural,Effusions, Pleural,Pleural Effusions
D002097 C-Reactive Protein A plasma protein that circulates in increased amounts during inflammation and after tissue damage. C-Reactive Protein measured by more sensitive methods often for coronary heart disease risk assessment is referred to as High Sensitivity C-Reactive Protein (hs-CRP). High Sensitivity C-Reactive Protein,hs-CRP,hsCRP,C Reactive Protein,High Sensitivity C Reactive Protein
D005260 Female Females
D005947 Glucose A primary source of energy for living organisms. It is naturally occurring and is found in fruits and other parts of plants in its free state. It is used therapeutically in fluid and nutrient replacement. Dextrose,Anhydrous Dextrose,D-Glucose,Glucose Monohydrate,Glucose, (DL)-Isomer,Glucose, (alpha-D)-Isomer,Glucose, (beta-D)-Isomer,D Glucose,Dextrose, Anhydrous,Monohydrate, Glucose
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
June 1965, Radiology,
E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
May 1982, Nihon Kyobu Shikkan Gakkai zasshi,
E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
August 1975, Chest,
E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
March 1970, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
April 2003, Acta pharmacologica Sinica,
E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
September 1980, Radiology,
E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
September 2000, American journal of respiratory and critical care medicine,
E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
December 2016, Forensic science, medicine, and pathology,
E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
November 1991, Chest,
E Kunter, and A Ilvan, and E Kilic, and K Cerrahoglu, and T Isitmangil, and F Capraz, and K Avsart
November 2011, Journal of applied biomechanics,
Copied contents to your clipboard!